BI
BIOGEN INC. Other
US US · SEC (Form 4)
Browse the full record of transactions filed by BIOGEN INC.. Director active across 1 companies, notably Sangamo Therapeutics, INC. In total, 12 disclosures have been logged. Total volume traded: €2.9m. The latest transaction was disclosed on 28 December 2021 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations 12 total
€20,761 2,764 shares @ €7.5111 0.014% mcap 1.4% of flow
Common Stock
SEC:0000875045-21-000061 · 28 Dec 2021
€20,761 2,764 shares @ €7.5111 0.014% mcap 0.7% of flow
Common Stock
SEC:0000875045-21-000061:0 · 28 Dec 2021
€613,062 81,187 shares @ €7.5512 0.42% mcap 42.8% of flow
Common Stock
SEC:0000875045-21-000060 · 23 Dec 2021
€613,062 81,187 shares @ €7.5512 0.42% mcap 21.4% of flow
Common Stock
SEC:0000875045-21-000060:0 · 23 Dec 2021
€178,520 23,660 shares @ €7.5452 0.12% mcap 12.5% of flow
Common Stock
SEC:0000875045-21-000059 · 9 Dec 2021
€178,520 23,660 shares @ €7.5452 0.12% mcap 6.2% of flow
Common Stock
SEC:0000875045-21-000059:0 · 9 Dec 2021
€393,771 52,178 shares @ €7.5467 0.27% mcap 27.5% of flow
Common Stock
SEC:0000875045-21-000058 · 7 Dec 2021
€393,771 52,178 shares @ €7.5467 0.27% mcap 13.7% of flow
Common Stock
SEC:0000875045-21-000058:0 · 7 Dec 2021
€5,493 730 shares @ €7.524 0.0037% mcap 0.4% of flow
Common Stock
SEC:0000875045-21-000057 · 1 Dec 2021
€5,493 730 shares @ €7.524 0.0037% mcap 0.2% of flow
Common Stock
SEC:0000875045-21-000057:0 · 1 Dec 2021
€221,626 28,884 shares @ €7.673 0.15% mcap 15.5% of flow
Common Stock
SEC:0000875045-21-000055 · 26 Nov 2021
€221,626 28,884 shares @ €7.673 0.15% mcap 7.7% of flow
Common Stock
SEC:0000875045-21-000055:0 · 26 Nov 2021
About BIOGEN INC. BIOGEN INC. is a director and insider at Sangamo Therapeutics, INC.